If the cells you would like to access are currently listed as unavailable
              or you are ordering from outside of Europe please get in touch via
              Contact@EBiSC.org.
          
    			WTSIi204-A
	
	HPSI0414i-oulr_2	
        			        			iPSC line
                                    A CLIP contains information about a cell line including any
                                    specific third party obligations relating to, for example,
                                    licensing obligations or the donor consent which affect the
                                    use of the cell line.
                                
                                                        
                                    The EBiSC Access and Use Agreement must be completed along with an individual
                                    Cell Line Information Pack for each line. Complete the EAUA and send to Contact@EBiSC.org
                                    for countersignature. The EAUA must be fully signed before proceeding with your order.
                                
                                                    
                                A batch specific Certificate of Analysis will be available to
                                download once you receive your EBiSC iPSC line.
                            
                        General#
| Cell Line | |
| hPSCreg name | WTSIi204-A | 
| Alternative name(s) | 
	HPSI0414i-oulr_2	 | 
| Cell line type | Human induced pluripotent stem cell (hiPSC) | 
| Similar lines |  | 
| Provider | |
| Depositor | Wellcome Sanger Institute (WTSI) | 
| Distributors | 
									EBiSC																																																																																																																																																																																		 | 
| Derivation country | United Kingdom | 
| External Databases | |
| hPSCreg | WTSIi204-A | 
| BioSamples | SAMEA3847989 | 
| HipSci | HPSI0414i-oulr_2 | 
| Cellosaurus | CVCL_AJ90 | 
| Wikidata | Q54890726 | 
| General Information | |
| This EBiSC line can be used for: | Yes Research use: allowed Clinical use: no Commercial use: no | 
Donor Information#
| General Donor Information | |
| Sex | male | 
| Age of donor (at collection) | 15-19 | 
| Ethnicity | Caucasian | 
| Phenotype and Disease related information (Donor) | |
| Diseases | A disease was diagnosed. | 
| Donor Relations | |
| Other cell lines of this donor |  | 
| External Databases (Donor) | |
| BioSamples | SAMEA2464827 | 
| HipSci | HPSI-oulr | 
hIPSC Derivation#
| General | |
| Source cell type | A leukocyte with a single non-segmented nucleus in the mature form. Synonyms 
 | 
| Source cell origin | A fluid that is composed of blood plasma and erythrocytes. Synonyms 
 | 
| Age of donor (at collection) | 15-19 | 
| Collected in | 2015 | 
| Source cell line vendor | University of Exeter Medical School | 
| Reprogramming method | |
| Vector type | Non-integrating | 
| Vector | Sendai virus | 
| Genes | |
| Notes on reprogramming vector detection | CytoTune 1 | 
| Vector free reprogramming | |
| Other | |
| Selection criteria for clones | Morphology | 
| Derived under xeno-free conditions | No | 
| Derived under GMP? | No | 
| Available as clinical grade? | No | 
Culture Conditions#
| Latest released batch | |
| Passage method | EDTA | 
| Surface coating | Vitronectin | 
| O2 concentration | 21 | 
| CO2 concentration | 5 | 
| Temperature | 37 | 
					The following are the depositor culture conditions, they do not refer to any specific batch.
				
			
			| Surface coating | Vitronectin | 
| Feeder cells | No | 
| Passage method | Enzyme-free cell dissociation 
											EDTA										 | 
| CO2 Concentration | 5 % | 
| Medium | TeSR™ E8™ | 
Characterisation#
Analysis of Undifferentiated Cells
| Marker | Expressed | Immunostaining | RT-PCR | Flow Cytometry | Enzymatic Assay | Expression Profiles | 
| POU5F1 (OCT-4) | Yes |  | ||||
| SSEA-1 | No |  | ||||
| SSEA-4 | Yes |  | ||||
| TRA 1-60 | Yes |  | 
| Pluripotency Score | Novelty Score | |
| 30.244 | 1.512 | 
Report
						HPSI-oulr.pluritest.pluripotency_score.20161010.png
pluripotency image
HPSI-oulr.pluritest.novelty_score.20161010.png
novelty image
| Microbiology / Virus Screening | |
| HIV 1 | Negative | 
| HIV 2 | Negative | 
| Hepatitis B | Negative | 
| Hepatitis C | Negative | 
| Mycoplasma | Negative | 
| Sterility | |
| Inoculation for microbiological growth | No Contaminants Detected | 
| Mycoplasma | Not Detected | 
| Viability | Viable post-cryopreservation | 
Genotyping#
| Karyotyping (Cell Line) | |
| Has the cell line karyotype been analysed? | No | 
| Other Genotyping (Cell Line) | |
| Is there genome-wide genotyping or functional data available? | Yes 
											Exome sequencing											
											 https://www.ebi.ac.uk/ega/studies/EGAS00001001140 
											cnv											
											 http://www.hipsci.org/lines/#/lines/HPSI0414i-oulr_2 Number of regions different from primary tissue: 0; Length of differences from primary tissue: 0 
											Methylation profiling											
											 https://ega-archive.org/datasets/EGAD00010001149 Text file with probe intensities | 
